Allergan Plays Defense Against Valeant

July 21 (Bloomberg) -- Valeant Pharmaceuticals CEO Michael Pearson discusses Valeant’s fight to acquire Allergan with Stephanie Ruhle and Erik Schatzker on “Market Makers.” (Source: Bloomberg)

Aspiration CEO's Approach to Sustainable Investing
59:03 - Andrei Cherny, Aspiration's chief executive officer, discusses his approach to sustainable investing with Bloomberg's Oliver Renick on "Bloomberg Markets." (Source: Bloomberg)
  • What Not to Miss in Alphabet's Earnings Report
  • S&P 500 Winners and Losers for 04/26
  • Bloomberg Markets Trump: First 100 Days 4/26